Grey Wolf

News

Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.

News

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on blockbuster immunology drug Enbrel.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.